Additionally, overexpression of ALOX5 with its related downstream metabolites has been reported in other cancers such as breast, esophageal, pancreatic, and prostate cancers by stimulation of cell proliferation, tumor angiogenesis, and survival (37). The gene discussed is ALOX5; the disease is prostate carcinoma.